{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-000632","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2023-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.852126+00:00","generated_at":"2026-06-20T19:31:02.921759+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"INVO Bioscience raises $375K in debt and warrant financings from investors and related party","bullets":["On Jan 4, 2023, company sold $275,000 in 10% convertible notes (conversion at $0.50) and 5-year warrants for 275k shares at $1.00.","On Dec 29, 2022, company obtained $100,000 demand note from JAG Multi Investments (CFO-related party) and issued warrant for 350k shares at $0.50.","JAG's prior $400k demand notes payment date extended to March 31, 2023; $350k is callable now.","Proceeds from both financings will be used for working capital and general corporate purposes.","Notes and warrants issued in unregistered private placement under Section 4(a)(2) and Rule 506."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-000632","json":"https://secwatch.observer/filing/0001493152-23-000632.json","markdown":"https://secwatch.observer/filing/0001493152-23-000632.md","text":"https://secwatch.observer/filing/0001493152-23-000632.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223000632/0001493152-23-000632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223000632/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T19:31:02.921759+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"30bc740c41e90f3043b83e0fca7a24dfcb86fa4e","claim":"INVO Fertility, Inc. amended loan of $400,000 with JAG Multi Investments LLC maturing March 31, 2023.","evidence_excerpt":"the date on which JAG can demand payment of principal, fees and any interest under those certain demand promissory previously issued to JAG by the Company for a total of $400,000, of which JAG may demand payment of $350,000 as of the date hereof, be extended to March 31, 2023","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223000632/0001493152-23-000632-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$400,000"},{"label":"Counterparty","value":"JAG Multi Investments LLC"},{"label":"Maturity","value":"March 31, 2023"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"3c0271935a4d43cdc0772575573ef765fa3239b3","claim":"INVO Fertility, Inc. incurred loan of $100,000 with JAG Multi Investments LLC at 10% annual interest.","evidence_excerpt":"with JAG Multi Investments LLC (“JAG”), a related party to Andrea Goren, our CFO, who is a beneficiary of JAG but does","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223000632/0001493152-23-000632-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$100,000"},{"label":"Counterparty","value":"JAG Multi Investments LLC"},{"label":"Rate","value":"10% annual interest"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"8cd14d5d8f0d2ed7f01441471486b5e54b0cc963","claim":"INVO Fertility, Inc. entered into Purchase Agreements with accredited investors valued at $275,000 (effective 2023-01-04).","evidence_excerpt":"the Company entered into definitive securities purchase agreements (the “Purchase Agreements”) with accredited investors for their purchase of (i) unsecured convertible notes of the Company in the aggregate original principal amount of $275,000","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223000632/0001493152-23-000632-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"accredited investors"},{"label":"Value","value":"$275,000"},{"label":"Effective","value":"2023-01-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}